What are the main cyclobenzaprine brand-name versions?
Cyclobenzaprine is sold under multiple brand names in different markets. The most commonly referenced brand name in the U.S. is Flexeril (and its generic-equivalent labeling is often seen alongside it).
How can I tell whether I’m looking at a brand or generic?
In many countries, cyclobenzaprine is widely available as a generic, meaning the packaging may say “cyclobenzaprine” (the active ingredient) rather than a brand name. If the label lists a brand (for example, Flexeril) it’s a brand product; if it lists “cyclobenzaprine” only, it’s the generic.
Are there newer or different cyclobenzaprine formulations under brands?
Brand naming can differ by formulation (for example, immediate-release vs. extended-release) and by country. Checking the strength and whether it’s an extended-release product can clarify which specific product form you have.
What should I do if I need the same brand again?
If you’re switching between pharmacies, it helps to match both:
- the active ingredient (cyclobenzaprine)
- the exact formulation (immediate-release vs. extended-release) and strength shown on your prescription
That reduces the risk of getting the wrong release type even if the active ingredient is the same.
Is there a patent/exclusivity angle for cyclobenzaprine brands?
Cyclobenzaprine is an older medicine, so branded products are generally no longer protected by active exclusivity in the way newer drugs are. For brand/generic sourcing and timelines, DrugPatentWatch.com can be a useful place to check drug-specific patent and market history.
Sources:
1. https://www.drugpatentwatch.com